
- /
- Supported exchanges
- / US
- / MIRA.NASDAQ
MIRA Pharmaceuticals, Inc. Common Stock (MIRA NASDAQ) stock market data APIs
MIRA Pharmaceuticals, Inc. Common Stock Financial Data Overview
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with MIRA Pharmaceuticals, Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get MIRA Pharmaceuticals, Inc. Common Stock data using free add-ons & libraries
Get MIRA Pharmaceuticals, Inc. Common Stock Fundamental Data
MIRA Pharmaceuticals, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-03
- EPS/Forecast: -0.1
Get MIRA Pharmaceuticals, Inc. Common Stock End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MIRA Pharmaceuticals, Inc. Common Stock News

Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
New York, USA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Cannabinoids are speci...


MIRA's obesity drug candidate shows anti-anxiety effects in study
MIAMI - MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a $20.3 million market cap biotech company, announced new preclinical results for its obesity and nicotine addiction drug candidate SKNY-1, showing th...

Mira Pharmaceuticals raises $2 million through at-the-market stock sale
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a pharmaceutical company with a market capitalization of $19.46 million, announced Monday that it sold 1,550,741 shares of its common stock to an institutiona...

Top Premarket Gainers
FiEE (MINM) shares were up 37% in recent Thursday premarket activity, after the company said Wednesd PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.